WASHINGTON – The Food and Drug Administration warned doctors Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit hyperactivity disorder. Manufacturer Eli Lilly & Co. announced that a black-box warning will be… Read More
Comments for: FDA issues warning on drug for ADHD
FDA issues warning on drug for ADHD
You may also like
FDA issues warning on drug for ADHD